rheumatoid arthritis
Anti-interleukin-6 receptor antibody therapy favors adrenal androgen secretion in patients with rheumatoid arthritis: a randomized, double-blind, placebo-controlled study.
Anti-<span class="gene" id="16729287-0-5-27">interleukin-6 receptor</span> antibody therapy favors adrenal androgen secretion in patients with <span class="disease" id="16729287-0-96-116">rheumatoid arthritis</span>: a randomized, double-blind, placebo-controlled study.